STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB)

Historical Holders from Q1 2014 to Q1 2025

Symbol
LAB on Nasdaq
CUSIP
34385P108
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
374M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
277M
Holdings value
$485M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
140
Number of buys
59
Number of sells
-62
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Casdin Capital, LLC 21.6% $83.7M 80.9M Eli Casdin Feb 28, 2025

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.02M $1.1M -$18K $1.08 9
2024 Q4 277M $485M -$5.99M $1.75 140
2024 Q3 280M $541M +$18.8M $1.93 140
2024 Q2 271M $479M -$3.83M $1.77 141
2024 Q1 265M $719M +$582M $2.71 145
2023 Q4 44.6M $98.7M +$76.9M $2.21 83
2023 Q3 880 $1.85K -$412K $2.10 1
2023 Q2 46.2M $89.1M +$15.3K $1.93 65
2023 Q1 46.1M $89.9M -$84.8K $1.95 68
2022 Q4 46.5M $54.4M -$780K $1.17 63
2022 Q3 38.6M $42.5M -$7.84M $1.10 59
2022 Q2 43.7M $69.9M -$16.2M $1.60 75
2022 Q1 49.1M $176M -$25.1M $3.59 100
2021 Q4 55.5M $217M -$15.4M $3.92 115
2021 Q3 58.6M $386M +$7.3M $6.59 114
2021 Q2 57.6M $354M +$244K $6.16 110
2021 Q1 58.7M $266M -$42.3M $4.52 132
2020 Q4 65.3M $392M -$13.6M $6.00 141
2020 Q3 65.4M $486M +$35.8M $7.43 129
2020 Q2 62.2M $249M -$3.15M $4.01 109
2020 Q1 59.7M $152M -$1.04M $2.54 97
2019 Q4 63.1M $220M -$9.65M $3.48 96
2019 Q3 63.9M $296M -$62.7M $4.63 122
2019 Q2 69.8M $860M +$95.1M $12.32 131
2019 Q1 64.3M $854M +$79.4M $13.29 130
2018 Q4 49.4M $426M +$92.7M $8.62 98
2018 Q3 38.8M $291M +$6.19M $7.49 76
2018 Q2 38.1M $227M +$7.21M $5.96 83
2018 Q1 37M $216M +$1.75M $5.84 82
2017 Q4 36.7M $217M +$4.38M $5.89 80
2017 Q3 36.2M $182M +$50.2M $5.04 76
2017 Q2 26.2M $106M -$4.73M $4.04 74
2017 Q1 27.1M $154M +$9.95M $5.69 77
2016 Q4 26.9M $196M -$9.62M $7.28 79
2016 Q3 27.2M $218M -$2.99M $8.01 89
2016 Q2 27.3M $246M -$14M $9.03 92
2016 Q1 28.5M $230M -$7M $8.07 92
2015 Q4 28.3M $306M -$18.7M $10.81 101
2015 Q3 30.9M $250M -$43.6M $8.11 99
2015 Q2 30.6M $741M -$48.2M $24.20 103
2015 Q1 28M $1.18B +$27.6M $42.10 102
2014 Q4 27.4M $925M +$53.4M $33.73 98
2014 Q3 28.6M $701M +$41.9M $24.50 97
2014 Q2 26.7M $784M -$1.61M $29.40 104
2014 Q1 25.8M $1.14B +$79.4M $44.07 104